Inhibition of DTYMK Significantly Restrains the Growth of HCC and Increases Sensitivity to Oxaliplatin

The authors revealed that deoxythymidylate kinase (DTYMK) levels significantly increased and correlated with poor prognosis in hepatocellular carcinoma (HCC).